Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Compare after-tax performance between ETFs and mutual funds to understand tax efficiency and potential savings for your portfolio.
26,741 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A revival in small-cap stocks is taking shape as three key forces converge. AI-driven demand, a steadier macro backdr...
New data shows many Americans over 50 have under 50k saved for retirement, highlighting a growing gap between savings...
A top OpenAI robotics executive has resigned amid concerns over guardrails for a Pentagon AI deal. The move signals t...
Markets swing between fear and opportunity. This guide shows how to identify a growth stock dynamo before a breakout,...
Bridgewater founder Ray Dalio warns that China’s ascent is shifting global power and investor risk. The commentary co...
A couple with a $240,000 annual income discovers a hidden transfer to the husband's parents, prompting questions abou...
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Missing pet posts are increasingly targeted by AI-powered scammers. Learn how these schemes work, the warning signs, ...
Ethereum slipped to around $1,650 as a new nonprofit research lab, ETHLabs, announced its mission to fix core network...
Pi Network rolls out new ecosystem tools to broaden utility, while PI token drifts lower in a cautious crypto market....
Bitcoin faces renewed pressure as a large overnight repo operation from the Federal Reserve coincides with stress in ...